PHAXIAM Therapeutics S.A. Recorded Big Gain
Tue, Sep 19, 2023 at 07:31 PM
PHAXIAM Therapeutics S.A. (PHXM:NASDAQ) jumped higher at $5.24, representing a gain of 30%. On Tue, Sep 19, 2023, PHXM:NASDAQ touched a New 2-Week High of $5.24. From Tue, Sep 05, 2023, the stock recorded 50.00% Up Days and 45.45% Green Days
About PHAXIAM Therapeutics S.A. (PHXM:NASDAQ)
Erytech Pharma SA is a clinical-stage biopharmaceutical company developing innovative therapies for severe forms of cancer and orphan diseases.
Top 10 Gainers:
- Connexa Sports Technologies Inc. (CNXA:NASDAQ), 160.11%
- Bird Global Inc. Class A (BRDS:NYSE), 103.59%
- Avinger, Inc. (AVGR:NASDAQ), 72.16%
- Rackspace Technology Inc. (RXT:NASDAQ), 35.81%
- Sezzle Inc. (SEZL:NASDAQ), 34.57%
- Elutia Inc Cl A Com (ELUT:NASDAQ), 33.06%
- PHAXIAM Therapeutics S.A. (PHXM:NASDAQ), 30.02%
- Kaspien Holdings Inc. (KSPN:NASDAQ), 27.84%
- Applied Therapeutics, Inc. (APLT:NASDAQ), 27.78%
- Orchestra BioMed Holdings Inc Com (OBIO:NASDAQ), 27.61%